Company: ARWR
Filing Date: 2025-01-29
Form Type: DEF 14A
Source: 0001628280-25-002848
Chunk: 14

Company: ARROWHEAD PHARMACEUTICALS, INC.
Filing Date: 2025-01-29
Form: DEF 14A
Chunk 14
---
 stated search criteria for exceptional candidates. The Nomination Committee assesses its effectiveness in achieving its goal of building a diverse board as part of its annual assessment of the composition of the Board. In 2018, the Board established a Science Committee to review and advise on science topics of interest to the Company. The members of the Science Committee for fiscal 2024 were Mauro Ferrari (Committee Co-Chair), Adeoye Olukotun (Committee Co-Chair), Douglass Given, and Michael Perry. The current members of the Science Committee for fiscal 2025 are Mauro Ferrari (Committee Co-Chair), Adeoye Olukotun (Committee Co-Chair), Hongbo Lu, and Michael Perry.

| 16 |

2025 PROXY STATEMENT Proposal One — Election of Directors Each of our incumbent directors attended 100% of the aggregate of (i) the total number of meetings of the Board held during fiscal 2024, and (ii) the total number of meetings held by all committees of the Board during fiscal 2024 on which such person served, in each case during the period in which such person served on the Board or committee. In addition, all of the directors then serving on the Board and standing for re-election attended the virtual 2024 Annual Meeting of Stockholders. It is the Company’s policy to encourage, but not require, that all directors attend our annual stockholder meetings.

| 17 |

Director Compensation Directors who are also employees of the Company receive no separate compensation from the Company for their service as members of the Board. For 2024, the Company maintained the structure of director compensation it adopted in 2019 to provide a base retainer for each director with higher base retainers for service by the Board Chair and committee leadership. The average total compensation paid to the Company's non-executive directors for service in 2024 is at or below the 60 th percentile of the total compensation paid to non-executive directors of its peer group as described later in this proxy statement. The Compensation Committee believes the structure aligns compensation according to the level of service contributions by each director. The fees payable to directors for service on the Board and for service on each committee of the Board on which the director serves are as follows:

| Board of Directors:                                         |     | 2023 Annual Retainer: |     | 2024 Annual Retainer: |
| All non-employee directors                                  |     |               $80,000 |     |               $80